The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04862663
Brief Title: Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) (CAPItello-292)
First Submitted : March 17, 2021
First Submitted that Met QC Criteria : April 23, 2021
First Posted : April 28, 2021
Last Update Submitted that Met QC Criteria : May 9, 2024
Last Update Posted : May 10, 2024 (Estimate)